Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Addus Homecare Corp (NASDAQ:ADUS)

30.85
Delayed Data
As of 3:59pm ET
 +0.20 / +0.65%
Today’s Change
16.55
Today|||52-Week Range
37.35
-11.98%
Year-to-Date
Orexigen Posts Wider-than-Expected Loss in Q4; Sales Up Y/Y
11:12am / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet
Mar 20 / Zacks.com - Paid Partner Content
Novo Nordisk: Positive CHMP Nod for Tresiba Label Expansion
Mar 28 / Zacks.com - Paid Partner Content
Owens & Minor (OMI) Reaffirms Tepid 2017 Financial Guidance
Mar 17 / Zacks.com - Paid Partner Content
VIVUS to Regain Commercial Rights for Stendra from Sanofi
Mar 28 / Zacks.com - Paid Partner Content
Teva Launches Authorized Generic of Allergan's Minastrin
Mar 17 / Zacks.com - Paid Partner Content
Roche's Rituxan Gets 'Breakthrough Therapy' Designation by FDA
Mar 24 / Zacks.com - Paid Partner Content
Jazz Initiates Phase III Study for Narcolepsy Candidate
Mar 16 / Zacks.com - Paid Partner Content
Allergan's Restasis Now Available in Multidose Bottle in U.S.
Mar 23 / Zacks.com - Paid Partner Content
Conatus Pharma (CNAT) Incurs Wider-than-Expected Loss in Q4
Mar 16 / Zacks.com - Paid Partner Content
Alexion (ALXN) Files for Soliris' Label Expansion in Japan
Mar 23 / Zacks.com - Paid Partner Content
TrovaGene (TROV) Reports Wider-than-Expected Loss in Q4
Mar 16 / Zacks.com - Paid Partner Content
Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study
Mar 23 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Reports Narrower-than-Expected Loss in Q4
Mar 16 / Zacks.com - Paid Partner Content
Keryx's Auryxia Added to Largest Medicare Part D Plan
Mar 22 / Zacks.com - Paid Partner Content
AstraZeneca's Cancer Drug Lynparza Positive in Phase III
Mar 15 / Zacks.com - Paid Partner Content
Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down
Mar 22 / Zacks.com - Paid Partner Content
Arena Pharmaceuticals (ARNA) Posts Q4 Earnings, Revenues Up
Mar 15 / Zacks.com - Paid Partner Content
Jazz Sleep Disorder Drug Positive in Phase III Studies
Mar 21 / Zacks.com - Paid Partner Content